97 related articles for article (PubMed ID: 11980132)
21. The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study.
Yee CS; Filer A; Pace A; Douglas K; Situnayake D; Rowe IF;
Rheumatology (Oxford); 2003 Jul; 42(7):856-9. PubMed ID: 12730544
[TBL] [Abstract][Full Text] [Related]
22. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
Kietzmann M; Meyer-Lindenberg A; Engelke A; Nolte I
Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
[TBL] [Abstract][Full Text] [Related]
24. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis.
Onda K; Rimbara E; Hirano T; Oka K; Abe H; Tahara K; Takanashi H; Tsuboi N; Niitsuma T; Hayashi T
J Rheumatol; 2004 Mar; 31(3):464-9. PubMed ID: 14994389
[TBL] [Abstract][Full Text] [Related]
25. Ocular bioavailability of topical prednisolone preparations.
Olejnik O; Weisbecker CA
Clin Ther; 1990; 12(1):2-11. PubMed ID: 2328525
[TBL] [Abstract][Full Text] [Related]
26. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions.
Mangin O; Zheng Y; Bouazza N; Foissac F; Benaboud S; Lui G; Hirt D; Mouthon L; Tréluyer JM; Urien S
Fundam Clin Pharmacol; 2020 Apr; 34(2):270-278. PubMed ID: 31625621
[TBL] [Abstract][Full Text] [Related]
27. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
[TBL] [Abstract][Full Text] [Related]
28. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
29. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
30. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H
Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.
Haringman JJ; Gerlag DM; Smeets TJ; Baeten D; van den Bosch F; Bresnihan B; Breedveld FC; Dinant HJ; Legay F; Gram H; Loetscher P; Schmouder R; Woodworth T; Tak PP
Arthritis Rheum; 2006 Aug; 54(8):2387-92. PubMed ID: 16869001
[TBL] [Abstract][Full Text] [Related]
33. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
[TBL] [Abstract][Full Text] [Related]
35. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.
Kondo H; Abe T; Hashimoto H; Uchida S; Irimajiri S; Hara M; Sugawara S
J Rheumatol; 2004 Feb; 31(2):243-51. PubMed ID: 14760792
[TBL] [Abstract][Full Text] [Related]
37. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
38. Novel transdermal targeting in steroid therapy: evaluation of PK/PD profiles using an animal model of rheumatoid arthritis.
Komuro M; Kakuo H; Sawada K; Kawaguchi Y
Pharmazie; 2002 Feb; 57(2):147. PubMed ID: 11878193
[No Abstract] [Full Text] [Related]
39. Prednisolone concentration in the cochlea of patients with perilymph fistula.
Oertel R; Kirch W; Klemm E
Pharmazie; 2007 Mar; 62(3):239-40. PubMed ID: 17416205
[TBL] [Abstract][Full Text] [Related]
40. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
Nishimoto N; Yoshizaki K; Maeda K; Kuritani T; Deguchi H; Sato B; Imai N; Suemura M; Kakehi T; Takagi N; Kishimoto T
J Rheumatol; 2003 Jul; 30(7):1426-35. PubMed ID: 12858437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
